Literature DB >> 3766870

Significance of ploidy in laryngeal cancer.

M M Goldsmith, D S Cresson, D S Postma, F B Askin, H C Pillsbury.   

Abstract

We studied 48 patients with laryngeal or hypopharyngeal primary tumors with DNA flow cytometry. Twenty-four of the tumors were glottic, 18 were supraglottic, and 6 were from the pyriform sinus. Patients were followed for a minimum of 12 months, with a mean follow-up of 23 months. Twenty-three of the 48 primary tumors (48 percent) were clearly aneuploid, 22 percent were tetraploid, and 30 percent were diploid. We concluded that patients with aneuploid primary tumors, high DNA levels, or both have a significantly better prognosis than those with diploid tumors, and this remained statistically significant when clinical outcome was adjusted for tumor status, stage, and nodal status.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3766870     DOI: 10.1016/0002-9610(86)90311-9

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  7 in total

1.  Nucleolar organizer regions in glottic carcinomas: comparison of DNA cytofluorometry and clinicopathological analysis.

Authors:  Y Yamamoto; T Itoh; T Saka; A Sakakura; H Takahashi
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

2.  Prognostic value of telomerase and DNA ploidy in laryngeal carcinoma.

Authors:  Talaat El Samny; Hisham El Halaby; Lobna El Fiky; Mohamed Nassar; Ali El Makhzangy; Sannaa Eissa
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-03-01       Impact factor: 2.503

3.  DNA index, cellular proliferative activity and nucleolar organizer regions in cancers of the larynx.

Authors:  J Cappiello; P Nicolai; A R Antonelli; F Facchetti; M Cadei; A Cornacchiari; P G Grigolato
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

4.  Cellular DNA content and prognosis in surgically treated squamous carcinoma of the larynx.

Authors:  L D Cooke; T G Cooke; G Forster; T R Helliwell; P M Stell
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

5.  A phase III randomised trial of cistplatinum, methotrextate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck. Liverpool Head and Neck Oncology Group.

Authors: 
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

6.  DNA gains and losses of chromosome in laryngeal squamous cell carcinoma using comparative genomic hybridization.

Authors:  Ibrahim Keser; Ahter D Toraman; Gulay Ozbilim; Kenan Guney; Guven Luleci
Journal:  Yonsei Med J       Date:  2008-12-31       Impact factor: 2.759

7.  DNA aneuploidy and low S-phase fraction as favourable prognostic signs in metastatic melanoma.

Authors:  T Muhonen; S Pyrhönen; A Laasonen; S Asko-Seljavaara; K Franssila
Journal:  Br J Cancer       Date:  1991-10       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.